Contract notice: Pharmaceutical products Tender in Poland - 31539627
Tender notice from Poland, published on 14 Mar 2019.
Executive Summary
The SZPITAL SPECJALISTYCZNY W ZABRZU SP. Z O.O. has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Poland. This Tender notice was published on 14 Mar 2019 and is scheduled to close on 22 Apr 2019, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 31539627, while the tender notice number is 118858-2019 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Body governed by public law Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union, with participation by GPA countries Award criteria: The most economic tender CPV code: 33600000, 33622100, 33622000, 33631300, 33631000, 33632100, 33670000, 33652300, 33600000, 33622100, 33622000, 33631300, 33631000, 33632100, 33670000, 33652300 CPV Description: Pharmaceutical products. Cardiac medical medicinal products. Medicinal products for the cardiovascular system. Antipsoriatics. Medicinal products for dermatology. Anti-inflammatory and anti-rheumatic products. Medicinal products for the respiratory system. Immunosuppressive agents. framework for the delivery of Drugs for drug programs for patients operated by the Specialist Hospital in ZabrzeSp. z o.o. Reference Number: DZP / 03PN / 2019 Framework contract for the supply of Drugs for drug programs for patients run by Szpital Specjalistyczny in Zabrze Sp. z o.o. DZP / 03PN / 2019 Main Site: Szpital Specjalistyczny w Zabrzu Sp. z o.o., ul. M. Curie-Skłodowskiej 10, 41-800 Zabrze, POLAND. Package No. 1 Sekukinumab. A detailed description of the subject of the order is attached as Annex 5 to the Terms of Reference forstock assortment. • Specific order requirements: 1) the period of validity of the products must be at least 75% of the total validity specified by the manufacturer. Deliveries of products with a shorter expiration date may be admitted in exceptional situations and the authorized representative of the Employer must agree to them each time. 2) time of order completionh - a point value in accordance with the provisions of the SIWZ part XV 3) the maximum time of order processing "for cito" 24 hours from placing the order or less, regardless of the value of the order, with the exception of Package No. 14 for which order "for cito" is 8 hours from ordering 4) Ordering allows use of an equivalent drug, i.e. a refractory (generic) 5) The equivalent drug must be spmake the following conditions: - will have the same dose and composition in the international name as the original medicine will have the same active substance as the original medicine will have the same form of medicine as the original medicine will have the same pharmaceutical availability as the original medicine will have the same bioavailability as the original drug will have the same bioequivalenceWhat is the original medicine - the same pharmacological action as the original medicine - the same authorization (indications) for use as the original medicine - in the case of an equivalent drug, ie a refinement (generic), the Contractor is obliged to offer medicinal products covered by the NFZ refund ( products must be registered in drug programs) and Contractors must attach toerty documents confirming possession of all features indicated in the description of the subject of the order, ie the CHPL (Product Characteristics) tab for a given equivalent drug. The Contractor is obliged to attach to the CHPL card offer only to medicinal products other than those specified in the Assortment and Price Form constituting an appendix to the Application. All other CHPL cards not listed inthe Contractor shall deliver at any request of the Employer. - Subject conditions required from the Contractors described in the SIWZ ch. III.3 SIWZ Chapter XIII.3.1 Powers: The Contractor must have the authorization to conduct business in the area of running a pharmaceutical wholesale store in accordance with the Act of 6.9.2001 Pharmaceutical Law (Journal of Laws from 2016.2142 with later amendments) applies to condition pkt 3.1.) In the form of the Single European Order Document (EED) in Section A of Part IV, the Contractor shall indicate the possessed qualifications referred to in point 3.1 required by the Employer pursuant to art. 22 par. 1b of the Act 4.4. The contractor whose offer will be highest assessed in order to demonstrate compliance with the conditions of participation in the proceedings (point 3.1 of this chapter of the ToR) will be calledto submit the following declarations and documents (valid as at the date of submitting declarations or documents) in accordance with Art. 24 aa of the Act: - in order to demonstrate fulfillment of the condition from item 3.1.: 4.4.1. original or copy, certified by the Contractor for compliance with the original authorization of the Main Pharmaceutical Inspector to conduct business in the field of running a farm wholesalerin accordance with the Act of 6.9.2001. Pharmaceutical Law (OJ 2016.2142, as amended). Note (applies to item 4.4.1) In the case of Contractors whose registered office is in a Member State of the European Union other than Poland, submission of the original or a copy certified by the Contractor is required for compliance with the original permit for running a pharmaceutical warehouse, issued pby a competent authority in a Member State of the European Union in which the Contractor has his registered office or place of residence, unless such a permit is not required in a given country - the Employer does not set any specific conditions in this respect. The Employer requires that during the whole period of the contract execution the Contractor has a valid insurance contract for civil liability, in the scope of the conductactivities related to the subject of the contract. The amount of the sum insured may not be less than the sum of the value of the offer for individual tasks (packages) for which the Contractor has concluded a contract with the Employer. The Contractor shall provide the Employer with a copy of the document confirming civil liability insurance before signing the contract, which will constitute Annex No. 1 to the contract. 2. Rchapter XIII.4.2 In order to confirm that the deliveries are delivered comply with the requirements specified by the Employer (Annex No. 5 to the ToR for the description of the subject of the order), the offer should be attached as at the date of submission of tenders: Annex No. 5 to the Terms of Reference for the description of the subject of the order form of range-range; The CHPL card (Summary of the Medicinal Product) for the offered drug - W przif you want to offer an equivalent drug, ie a refractory (generic) other than the one given in the Assortment and Price Form constituting Appendix No. 5 to the Terms of Reference. The Contractor is obliged to offer medicinal products covered by the NFZ refund (products must be registered in drug programs) and Contractors must attach to the offer documents confirming the possession of all the features indicated in the opithe order of the product, ie the CHPL card (Summary of medicinal product) for a given equivalent medicine. Documents submitted on request: CHPL card (Summary of Product Characteristics) for the offered medicine. 3. The Awarding Entity will exclude from the Contractor's proceedings in cases referred to in art. 24 section 1 point 12-23 of the Act (grounds for mandatory exclusion) in accordance with the SIWZ ch. XIII.Section 2. In order to demonstrate the absence of grounds for exclusion from the tender, the offer must be accompanied by a declaration, in the form of: Single Form European Order Document (EED) - Annex 2 to the Terms of Reference. The information contained in the EED is a preliminary confirmation that the Contractor is not subject to exclusion from the proceedings. EAT should be submitted together with the offer, in a separate onem file in electronic form with a qualified electronic signature. The contractor whose offer will be the highest rated, in order to demonstrate the absence of grounds for exclusion from the procurement procedure, will be requested to submit: Information from the National Criminal Register in the scope specified in art. 24 sec. 1 points 13, 14 and 21 of the Act, issued not earlier than 6 monthsd the deadline for submission of offers; The Contractor's statements that he has not issued a final court judgment or final administrative decision about default of taxes, fees or social security or health insurance premiums or in the event of such a verdict or decision confirming the payment of such claims together with any interest orfines or the conclusion of a binding agreement regarding the repayment of these debts (according to the information of EED part III B); Contractor's statements about the lack of a ruling against him as a preventive measure for the prohibition of applying for public orders (according to the information of EED part III.D). 4. The Awarding Entity does not provide for the ordering referred to in art. 67 section 1 item 7 of the Public Procurement Law 5. CLAUSE INFORMACIEJ THE RESULTING FROM ART. 13 and ART. 14 OF THE RHODE described in the SIWZ ch. XIX. 6. When choosing the most advantageous offer, the Ordering Party will be guided by the following criteria: the price is 90% of the order completion time is 10%. 7. SIWZ Chapter XIX. The offer must be secured by a bid bond. In the event of an offer being submitted for more than one task, a deposit must be paid in the total amount corresponding to the sum forindividual packages on which the offer is made. When making a deposit, indicate which packages are affected. Internet address (URL): www.klinika-zabrze.med.pl
The bid deadline for Contract notice: Pharmaceutical products was 22 Apr 2019. Bidding is closed.
This tender has been issued by SZPITAL SPECJALISTYCZNY W ZABRZU SP. Z O.O. in Poland.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products, 33622100 - Cardiac therapy medicinal products, 33622000 - Medicinal products for the cardiovascular system, 33631300 - Antipsoriatics, 33631000 - Medicinal products for dermatology, 33632100 - Anti-inflammatory and anti-rheumatic products, 33670000 - Medicinal products for the respiratory system, 33652300 - Immunosuppressive agents.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 31539627. The purchaser document reference is 118858-2019.